STEPHANIE REINHARD: Open Payments
NPI 1194299552 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 11 payments from 8 companies in 2025. Trend: 2023 $1,189 · 2024 $671 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $112 |
| Lilly USA, LLC | 3 | $71 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $21 |
| Melinta Therapeutics, LLC | 1 | $19 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $18 |
Products named: Leqembi, KISUNLA, ZERBAXA, OMVOH, ULTOMIRIS, BLENREP, TREMFYA, Rezzayo.
Industry payments across SC — which companies pay providers there.
